BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Big Cap Pro

1 year 30%, 2 years 40% and *3 years 50%

*Across 3 years $2276.64 only $1138.32

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,032.38
0.56%
US Tech 100
20,389.60
0.88%
Dow Jones
44,910.65
0.42%
Brent Oil
72.395
0.44%
Bitcoin
95,941.11
-1.36%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Ose Immunotherapeutics Sa (0RAD) Quote

Ose Immunotherapeutics Sa

Ose Immunotherapeutics Sa (0RAD)

LSE
4.12
0.00
(0.00%)
Closed December 02 11:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
4.12
Bid
0.00
Ask
0.00
Volume
0.00
0.00 Day's Range 0.00
4.12 52 Week Range 4.12
Market Cap
89.202M
Previous Close
4.12
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
98
Shares Outstanding
21,651,000
Dividend Yield
-
PE Ratio
-8.31
Earnings Per Share (EPS)
-1.06
Revenue
2.23M
Net Profit
-23M

About Ose Immunotherapeutics Sa

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
www.ose-immuno.com
Headquarters
Nantes, Loire-atlantique, Fra
Founded
-
Ose Immunotherapeutics Sa is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker 0RAD. The last closing price for Ose Immunotherapeutics was 4.12 €. Over the last year, Ose Immunotherapeutics shares have traded in a share price range of 4.12 € to 4.12 €.

Ose Immunotherapeutics currently has 21,651,000 shares outstanding. The market capitalization of Ose Immunotherapeutics is 89.20 € million. Ose Immunotherapeutics has a price to earnings ratio (PE ratio) of -8.31.

Ask ADVFN Intelligence (AI)

0RAD Latest News

More News

Informations relatives au nombre total de droits de vote et d’actions composant le capital

Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 4 novembre 2024 – En application de l’article L. 233-8 II du Code de commerce et de l’article...

November 04 2024
UK Regulatory

OSE Immunotherapeutics Annonce des Résultats Cliniquement Probants et Statistiquement Significatifs de l’Étude de Phase 2 de l’Anticorps Anti-IL7R Lusvertikimab pour le Traitement de la Rectocolite Hémorragique

OSE Immunotherapeutics Annonce des Résultats Cliniquement Probants et Statistiquement Significatifs de l’Étude de Phase 2 de l’Anticorps Anti-IL7R Lusvertikimab pour le Traitement de la...

November 04 2024
UK Regulatory

OSE Immunotherapeutics Announces Statistically Significant and Clinically Meaningful Results from the Phase 2 Study of Anti-IL7R mAb Lusvertikimab for the Treatment of Ulcerative Colitis

OSE Immunotherapeutics Announces Statistically Significant and Clinically Meaningful Results from the Phase 2 Study of Anti-IL7R mAb Lusvertikimab for the Treatment of Ulcerative Colitis OSE...

November 04 2024
UK Regulatory

OSE Immunotherapeutics présente une nouvelle technologie bispécifique de « Cis-Démasquage » pour la conception de médicaments à base de cytokines avec un indice thérapeutique amélioré

OSE Immunotherapeutics présente une nouvelle technologie bispécifique de « Cis-Démasquage » pour la conception de médicaments à base de cytokines avec un indice thérapeutique amélioré OSE...

October 17 2024
UK Regulatory

OSE Immunotherapeutics Presents New “Cis-Demasking” Bispecific Technology for the Design of Cytokine Drugs with Improved Therapeutic Index

OSE Immunotherapeutics Presents New “Cis-Demasking” Bispecific Technology for the Design of Cytokine Drugs with Improved Therapeutic Index NANTES, France, October 17, 6:00pm CET - OSE...

October 17 2024
UK Regulatory

Informations relatives au nombre total de droits de vote et d’actions composant le capital

Informations relatives au nombre total de droits de vote et d’actions composant le capital al Nantes, le 2 octobre 2024 – En application de l’article L. 233-8 II du Code de commerce et de...

October 02 2024
UK Regulatory

OSE Immunotherapeutics annonce des résultats semestriels 2024 remarquables et fait le point sur ses avancées

OSE Immunotherapeutics annonce des résultats semestriels 2024 remarquables et fait le point sur ses avancées OSE Immunotherapeutics annonce des résultats semestriels 2024 remarquables et fait le...

September 26 2024
UK Regulatory

OSE Immunotherapeutics Announces Historic H1 2024 Results and Provides Corporate Update

OSE Immunotherapeutics Announces Historic H1 2024 Results and Provides Corporate Update OSE Immunotherapeutics Announces Historic H1 2024 Results and Provides Corporate Update Financial and...

September 26 2024
UK Regulatory

OSE Immunotherapeutics annonce le lancement international d’Artemia, l’étude de Phase 3 d’enregistrement du vaccin thérapeutique Tedopi® en deuxième ligne de traitement du cancer du poumon non à petites cellules

OSE Immunotherapeutics annonce le lancement international d’Artemia, l’étude de Phase 3 d’enregistrement du vaccin thérapeutique Tedopi® en deuxième ligne de traitement du cancer du poumon non à...

September 10 2024
UK Regulatory

OSE Immunotherapeutics Announces Global Launch of Artemia Phase 3 Registration Study for Cancer Vaccine Tedopi® in Second-Line Non-Small Cell Lung Cancer

OSE Immunotherapeutics Announces Global Launch of Artemia Phase 3 Registration Study for Cancer Vaccine Tedopi® in Second-Line Non-Small Cell Lung Cancer OSE Immunotherapeutics Announces Global...

September 10 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1004.124.124.12164.12DE
4004.124.124.12314.12DE
12004.124.124.12984.12DE
26004.124.124.122434.12DE
52004.124.124.126904.12DE
156004.124.124.127604.12DE
260004.124.124.128854.12DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
0A2IH World Group Ltd
$ 0.00
(0.00%)
0
0A2DCrh Plc
$ 0.00
(0.00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
$ 0.00
(0.00%)
0
0A22Anheuser Busch Inbev Nv
$ 0.00
(0.00%)
0
0A1UUber Technologies Inc
$ 72.15
(0.00%)
2.94k
0A2IH World Group Ltd
$ 0.00
(0.00%)
0
0A2DCrh Plc
$ 0.00
(0.00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
$ 0.00
(0.00%)
0
0A22Anheuser Busch Inbev Nv
$ 0.00
(0.00%)
0
0A1UUber Technologies Inc
$ 72.15
(0.00%)
2.94k
0R0XTesla Inc
$ 339.20
(0.00%)
18.68k
0A6LGamestop Corp
$ 29.9025
(0.00%)
3.63k
0HCIAlibaba Group Holding Ltd
$ 86.90
(0.00%)
3.07k
0A1UUber Technologies Inc
$ 72.15
(0.00%)
2.94k
0R1OAmazon.com Inc
$ 206.00
(0.00%)
2.03k

Discussion

View Full Feed
AlwaysOptimistic AlwaysOptimistic 6 minutes ago
Great find GE. Hopefully, he can Make NioCorp Great Again!
NB
boogeyman6757565 boogeyman6757565 9 minutes ago
https://community.geotab.com/s/question/0D5Pd00000Rz3b0KAB/how-do-i-contact-blockchain-support-number-usa?language=en_US
https://community.geotab.com/s/question/0D5Pd00000Rz3b0KAB/how-do-i-contact-blockchain-support-number-usa?language=en_US
Krombacher Krombacher 9 minutes ago
SSC’s Endless Negativity: Let’s Address the Facts

1. Stock Performance
Yes, ERHC’s stock has declined over the years, but your constant harping on the historical decline ignores the nuance of long-term investment strategies. My positions have always been based on logical specul
ERHE
skeptical G skeptical G 12 minutes ago
was hoping for a Ravens win
IGPK
bbotcs bbotcs 17 minutes ago
Biden pardoned Hunter. Said he wouldn't, but we knew he would and he did. Who is going to pardon Joe?
bbotcs bbotcs 19 minutes ago
lj: SMCI
Bought shares at $35 and change last week. If the company survives, the purchase price will be a bargain in a year or so.
SMCI
Nrdc92 Nrdc92 19 minutes ago
That's how these cults work, Dan. The members are systematically groomed and then brainwashed, the result of which is to be unable to process facts outside the cult dogma. Here, it's even worse because the cult members have a financial stake in the cult, which provides additional incentive to remain
LWLG
nowwhat2 nowwhat2 21 minutes ago
Wooo-wooo !

https://investorshub.advfn.com/uimage/uploads/2024/12/2/evqdeLTC_111111_27_30d_chan.jpg




https://investorshub.advfn.com/uimage/uploads/2024/12/2/qrlzkltc_111111_30_30d_1pm_TL_W.jpg




https://investo
LTCUSD
Fdc4 Fdc4 31 minutes ago
I would believe such from anything else but from HMBL. This is a ponzi mate, down it goes, no escape to nobody. Careful, CEO watching for more dilution space expansion
HMBL
Fdc4 Fdc4 34 minutes ago
No FINRA or audit financials, I doubt this will see $0.006 again. Forget about $0.009, this is going down to trips
IGPK
Fdc4 Fdc4 36 minutes ago
Now your are talking about your beliefs. Did you know your beliefs aren’t aligned with the real facts? If you want others to mind their business, keep your nonsense to yourself mate. Nobody want to hear a pumper that doesn’t have idea of what he is talking about. Chill kid
IGPK
Biotechotcguy Biotechotcguy 36 minutes ago
Don't bet against the Jews. I'm in this till the end. 
DROR
sunspotter sunspotter 37 minutes ago
Still howling at the moon, chazzy?

Time to admit that both HDVY and VPLM are both insider enrichment scams masquerading as wannabe patent trolls.
HDVY VPLM
Fdc4 Fdc4 40 minutes ago
Good points Orca, well put
VDRM
BDEZ BDEZ 1 hour ago
No more income tax, Tariffs only. Do it
gitreal gitreal 1 hour ago
All that is a waste of time. You assume the assets are worth what they say they are. With no audit and all the other shady/sketchy stuff going on, probably should assume the assets are worthless.
BMXI
BDEZ BDEZ 1 hour ago
The real reason for the pardon

Biden,who will not even meet with his grand daughter Navy, didn’t pardon his son because he’s a good father. He did so because, as his son admits on the Hard Drive, for 30 years Hunter has given half the millions he’s collected to the Boss of the Crime F
BDEZ BDEZ 1 hour ago
Now I understand why Joe is fleeing to Africa. The Bidens are trying to hit the reset button on life, but it doesn’t quite work that way. Their lenders are coming to collect.

https://x.com/niceblackdude/status/1863458868904313077
cadillacdave cadillacdave 1 hour ago
That would be my guess as well- somewhere between $100-$120.
IONQ
BDEZ BDEZ 1 hour ago
Michael Saylor of MicroStrategy, $MSTR, has officially presented to the board of Microsoft, $MSFT, to adopt Bitcoin.
MSFT MSTR
BDEZ BDEZ 1 hour ago
Michael Saylor of MicroStrategy, $MSTR, has officially presented to the board of Microsoft, $MSFT, to adopt Bitcoin.
MSFT MSTR
BDEZ BDEZ 1 hour ago
Three things are certain:

1. Death
2. Taxes
3. Counting votes three weeks after an election will always result in a Democrat win.

Your Recent History

LSE
0RAD
Ose Immunotherapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Big Cap Pro

1 year 30%, 2 years 40% and *3 years 50%

*Across 3 years $2276.64 only $1138.32